Hepatic osteodystrophy: An underrecognized metabolic bone disease

doi:10.4254/wjh.v17.i8.109093

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (44)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-2)

Sum=43

Aug 27, 2025 (publication date) through Aug 27, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Aug 27, 2025; 17(8): 109093
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.109093

Full Size Figure Download Figure

Figure 3 Diagnosis and treatment of bone disorders among patients with chronic liver disease[80]. ¹According to the severity of liver disease and cholestasis, and in patients taking steroids; ²Calcium (1000–1500 mg/day) and vitamin D (400–800 IU/day) are necessary to maintain normal levels; ³Depending on additional risk factors. DXA: Dual energy X-ray absorptiometry.

Citation: Pramanik S, Palui R, Ray S. Hepatic osteodystrophy: An underrecognized metabolic bone disease. World J Hepatol 2025; 17(8): 109093
URL: https://www.wjgnet.com/1948-5182/full/v17/i8/109093.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i8.109093